Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

Alessio Cortellini(University of L'Aquila), Rita Chiari(Ospedale Santa Maria), Biagio Ricciuti(Ospedale Santa Maria), Giulio Metro(Ospedale Santa Maria), Fabiana Perrone(University of Parma), Marcello Tiseo(University of Parma), Melissa Bersanelli(University of Parma), Paola Bordi(University of Parma), Daniele Santini(Università Campus Bio-Medico), Raffaele Giusti(Sapienza University of Rome), Antonino Grassadonia(University of Chieti-Pescara), Pietro Di Marino(Ospedale SS. Annunziata), Nicola Tinari(Sapienza University of Rome), Michele De Tursi(Sapienza University of Rome), Federica Zoratto(Ospedale Santa Maria Goretti), Enzo Veltri(Ospedale Santa Maria Goretti), Francesco Malorgio(Ospedale di Santo Spirito), Carlo Garufi(Ospedale di Santo Spirito), Marco Russano(Università Campus Bio-Medico), Cecilia Anesi(Università Campus Bio-Medico), Tea Zeppola(Università Campus Bio-Medico), Marco Filetti(Sapienza University of Rome), Paolo Marchetti(Sapienza University of Rome), Rossana Berardi(Marche Polytechnic University), Silvia Rinaldi(Marche Polytechnic University), Marianna Tudini(Centro di Riferimento Oncologico), Rosa Rita Silva(Centro di Riferimento Oncologico), Annagrazia Pireddu(University of Cagliari), Francesco Atzori(University of Cagliari), Daniela Iacono(Carlo Forlanini Hospital), Maria Rita Migliorino(Carlo Forlanini Hospital), Giampiero Porzio(University of L'Aquila), Katia Cannita(University of L'Aquila), Corrado Ficorella(University of L'Aquila), Sebastiano Buti(University of Parma)
Clinical Lung Cancer
February 23, 2019
Cited by 178

Abstract


Related Papers

No related papers found

Powered by citation graph analysis